In addition, Silwal-Pandt et al. analyzed a series of 1,420 breast cancer patients from the METABRIC cohort and showed that 9.3 % of luminal A and 24.5 % of luminal B tumors harbored mutated TP53 [34]. Here, TP53 is linked to breast cancer.